Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma

Neuro Oncol. 2017 Apr 1;19(4):469-474. doi: 10.1093/neuonc/nox030.
No abstract available

Keywords: clinical trials; newly diagnosed glioblastoma; phase II; randomized; single-arm.

MeSH terms

  • Brain Neoplasms / drug therapy*
  • Clinical Trials, Phase II as Topic*
  • Dacarbazine / therapeutic use*
  • Glioblastoma / diagnosis
  • Glioblastoma / drug therapy*
  • Humans
  • Randomized Controlled Trials as Topic*
  • Treatment Outcome

Substances

  • Dacarbazine